[HTML][HTML] Understanding and managing withdrawal syndromes after discontinuation of antidepressant drugs

GA Fava, F Cosci - The Journal of clinical psychiatry, 2019 - psychiatrist.com
Withdrawal symptoms commonly occur during tapering and/or after discontinuation of
antidepressant drugs, particularly selective serotonin reuptake inhibitors and serotonin …

Mood and anxiety disorders as early manifestations of medical illness: a systematic review

F Cosci, GA Fava, N Sonino - Psychotherapy and psychosomatics, 2015 - karger.com
Background: Affective disturbances involving alterations of mood, anxiety and irritability may
be early symptoms of medical illnesses. The aim of this paper was to provide a systematic …

The reappraisal of benzodiazepines in the treatment of anxiety and related disorders

V Starcevic - Expert Review of Neurotherapeutics, 2014 - Taylor & Francis
Benzodiazepines (BDZs) continue to be shrouded in controversy, mainly because of
dependence associated with their long-term use and some of their side effects. Despite …

Suicides and suicide attempts during long-term treatment with antidepressants: a meta-analysis of 29 placebo-controlled studies including 6,934 patients with major …

C Braun, T Bschor, J Franklin, C Baethge - Psychotherapy and …, 2016 - karger.com
Background: It is unclear whether antidepressants can prevent suicides or suicide attempts,
particularly during long-term use. Methods: We carried out a comprehensive review of long …

Discontinuing antidepressant drugs: lesson from a failed trial and extensive clinical experience

GA Fava, C Belaise - Psychotherapy and Psychosomatics, 2018 - karger.com
Scholten et al.[1] reported on the first randomized controlled trial that attempted to prevent
relapse in patients with remitted anxiety disorder who discontinued antidepressant drugs …

Trends in antidepressant use and expenditure in six major cities in China from 2013 to 2018

Z Yu, J Zhang, Y Zheng, L Yu - Frontiers in Psychiatry, 2020 - frontiersin.org
The objective of this study was to investigate the current status and trends in antidepressant
use and expenditure in China from 2013 to 2018. The study had a retrospective design …

The deceptive manifestations of treatment resistance in depression: a new look at the problem

GA Fava, F Cosci, J Guidi, C Rafanelli - Psychotherapy and …, 2020 - karger.com
In the past decade, the number of papers dealing with treatment resistance in depression
has increased to a considerable degree. It has recently been discussed whether current …

The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: an integrative review of evidence, mechanisms, and clinical …

M Fornaro, A Anastasia, S Novello, A Fusco… - Pharmacological …, 2019 - Elsevier
The re-emergence (ie 'breakthrough') of depressive symptoms despite maintenance
treatment of depression with antidepressant drugs is a complex clinical phenomenon …

Second-generation antipsychotic drugs in anorexia nervosa: a meta-analysis of randomized controlled trials

M Dold, M Aigner, M Klabunde, J Treasure… - Psychotherapy and …, 2015 - karger.com
Background: Second-generation antipsychotic drugs (SGAs) are increasingly administered
to achieve weight gain in anorexia nervosa. In this meta-analysis, we aimed to determine if …

[HTML][HTML] Methodological flaws, conflicts of interest, and scientific fallacies: implications for the evaluation of antidepressants' efficacy and harm

MP Hengartner - Frontiers in psychiatry, 2017 - frontiersin.org
Background In current psychiatric practice, antidepressants are widely and with ever-
increasing frequency prescribed to patients. However, several scientific biases obfuscate …